Clark RA - Search Results

1

Dose-ranging trial of zacopride: the emetic antiemetic?

Pisters KM, Kris MG, Tyson LB, Clark RA, Gralla RJ. Pisters KM, et al. Among authors: clark ra. J Natl Cancer Inst. 1992 May 6;84(9):717-8. doi: 10.1093/jnci/84.9.717. J Natl Cancer Inst. 1992. PMID: 1569606 Clinical Trial. No abstract available.

2

Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and a review of completed trials to manage delayed emesis.

Kris MG, Tyson LB, Clark RA, Gralla RJ. Kris MG, et al. Among authors: clark ra. Cancer. 1992 Aug 15;70(4 Suppl):1012-6. Cancer. 1992. PMID: 1386282 Review.

3

Phase II trials of the serotonin antagonist GR38032F for the control of vomiting caused by cisplatin.

Kris MG, Gralla RJ, Clark RA, Tyson LB. Kris MG, et al. Among authors: clark ra. J Natl Cancer Inst. 1989 Jan 4;81(1):42-6. doi: 10.1093/jnci/81.1.42. J Natl Cancer Inst. 1989. PMID: 2521184 Clinical Trial.

4

Dose-ranging antiemetic trial of high-dose oral metoclopramide.

Tyson LB, Gralla RJ, Kris MG, Young CW, Clark RA. Tyson LB, et al. Among authors: clark ra. Am J Clin Oncol. 1989 Jun;12(3):239-43. doi: 10.1097/00000421-198906000-00012. Am J Clin Oncol. 1989. PMID: 2658539 Clinical Trial.

5

Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapy.

Kris MG, Gralla RJ, Clark RA, Tyson LB. Kris MG, et al. Among authors: clark ra. J Clin Oncol. 1988 Apr;6(4):659-62. doi: 10.1200/JCO.1988.6.4.659. J Clin Oncol. 1988. PMID: 2965755

6

Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial.

Kris MG, Gralla RJ, Clark RA, Tyson LB, Groshen S. Kris MG, et al. Among authors: clark ra. Cancer. 1987 Dec 1;60(11):2816-22. doi: 10.1002/1097-0142(19871201)60:11<2816::aid-cncr2820601137>3.0.co;2-7. Cancer. 1987. PMID: 3315176 Clinical Trial.

7

Randomized phase II trial comparing two versus three doses of ondansetron when used in combination with dexamethasone in patients receiving cisplatin > or = 100 mg/m2.

Tyson LB, Kris MG, Baltzer L, Pisters KM, Rigas JR, Clark RA. Tyson LB, et al. Among authors: clark ra. Am J Clin Oncol. 1994 Jun;17(3):269-72. doi: 10.1097/00000421-199406000-00018. Am J Clin Oncol. 1994. PMID: 8192116 Clinical Trial.

8

Dose-ranging antiemetic evaluation of the serotonin antagonist tropisetron in patients receiving anti-cancer chemotherapy.

Pisters KM, Kris MG, Tyson LB, Clark RA, Gralla RJ. Pisters KM, et al. Among authors: clark ra. Cancer. 1993 Jan 1;71(1):226-30. doi: 10.1002/1097-0142(19930101)71:1<226::aid-cncr2820710135>3.0.co;2-t. Cancer. 1993. PMID: 8416720

9

Dose-ranging evaluation of the substituted benzamide dazopride when used as an antiemetic in patients receiving anticancer chemotherapy.

Grant SC, Kris MG, Gralla RJ, Clark RA, Tyson LB. Grant SC, et al. Among authors: clark ra. Cancer Chemother Pharmacol. 1993;31(6):442-4. doi: 10.1007/BF00685032. Cancer Chemother Pharmacol. 1993. PMID: 8453682

10

Oral combination antiemetics in patients with small cell lung cancer receiving cisplatin or cyclophosphamide plus doxorubicin.

Cleri LB, Kris MG, Tyson LB, Pisters KM, Clark RA, Gralla RJ. Cleri LB, et al. Among authors: clark ra. Cancer. 1995 Sep 1;76(5):774-8. doi: 10.1002/1097-0142(19950901)76:5<774::aid-cncr2820760510>3.0.co;2-5. Cancer. 1995. PMID: 8625179 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,269 results

Search Page

Filters